Purpose. Candida biofilm infections are frequently linked to the use of biomaterials and are of clinical significance because they are commonly resistant to antifungals. Clioquinol is an antiseptic drug and is effective against multidrug-resistant Candida. We investigated the effect of clioquinol and two other 8-hydroxyquinoline derivatives on Candida biofilm.
INTRODUCTION
Vulvovaginal candidiasis (VVC) affects millions of women and is a very common cause of acute vaginitis [1] . It is estimated that approximately 75 % of women experience at least one episode of VVC during life, and approximately 40-50 % of them have additional episodes [2] . Furthermore, 5 % of them develop repetitive episodes (3-4 times in a period of 12 months) -a condition known as recurrent VVC [1] . The use of intrauterine devices (IUDs) as a contraceptive has not yet been recognized as a predisposing factor [3] ; however, previous studies have shown that women who use IUDs have more VVC infection than those who do not use the device [4] . Auler et al. described two cases of patients with signs and symptoms of recurrent VVC who used IUDs as a contraceptive method. Their findings indicated the presence of biofilm on the surface of the IUDs, and verified that the absence of this source of microorganisms was essential to avoid relapses in these patients [5] . In addition, intrauterine fetal death and maternal sepsis by Candida in women with IUDs has also been previously reported [6, 7] .
Device-associated infections are commonly related to biofilm: complex structured communities of microorganisms that are adherent at a surface or interface and encased within a polysaccharide-rich extracellular matrix [8] . Candida biofilms are of key clinical and economic significance because they are commonly resistant to antifungals, including azoles, polyenes and echinocandins [9, 10] . The presence of biofilm on the surface of the IUD helps to protect yeast from the action of antifungal agents, thereby contributing to the persistence of the microorganisms at the site and leading to recurrent infections [5] . Thus, the eradication of a biofilm usually involves treatment with toxic concentrations of drugs, and the recommended procedure includes removal of the contaminated device [11] . Therefore, biofilm formation in IUDs and treatments that can control this process require further investigation.
Clioquinol (5-chloro-7-iodo-8-hidroxyquinoline) is an 8-hydroxyquinoline derivative available as a topical medicine for antiseptic treatment [12] . In 1970, their oral formulations were withdrawn from the market due to reports of subacute myelo-optic neuropathy (SMON) in Japanese patients [13] . However there is still controversy regarding the association of the use of clioquinol and SMON [14] . Recently the interest in this drug reappeared as a potential treatment for several pathologies [15] [16] [17] [18] . Clioquinol has been demonstrated to be very effective against certain clinically important fungi, especially Candida spp. and dermatophytes, and it is also active against those isolates displaying multidrug resistance [19] . Furthermore, there are few reports of antimicrobial resistance against clioquinol [20] .
Considering such properties and the lack of studies of the effects of clioquinol on fungal biofilms, the aim of this study was to investigate the action of clioquinol 1 and two other 8-hydroxyquinoline derivatives (8-hydroxy-5-quinolinesulfonic acid 2 and 8-hydroxy-7-iodo-5-quinolinesulfonic acid 3) (Fig. 1) on Candida biofilms. Their ability to inhibit biofilm formation, to inhibit preformed biofilm and to remove established biofilms was evaluated on microtitre plates. The ability of Candida spp. to form biofilms on intrauterine copper devices (copper IUDs) and the action of clioquinol 1 on these was also investigated.
METHODS

Fungal strains
Biofilm assays was carried out with one strain of each Candida species studied (C. albicans ATCC 18804, C. glabrata CG RL24, C. krusei CK Den 43, C. parapsilosis CP RL38 and C tropicalis ATCC 750). All isolates were deposited in the Mycology Collection of Universidade Federal do Rio Grande do Sul (Porto Alegre, Brazil) and were obtained from ATCC (American Type Culture Collection, Manassas, VA) and clinical samples.
Antifungal compounds
Clioquinol (compound 1), 8-hydroxy-5-quinolinesulfonic acid (compound 2), 8-hydroxy-7-iodo-5-quinolinesulfonic acid (compound 3) and fluconazole were purchased from Sigma-Aldrich (St. Louis, MO). Compounds 1-3 were dissolved in DMSO (Sigma-Aldrich) and diluted in medium assay (RPMI 1640: Roswell Park Memorial Institute 1640; Gibco, NY) to obtain a maximum concentration of 2 % DMSO for the experiments. Fluconazole was directly diluted in medium assay.
Susceptibility of planktonic Candida cells to 8-hydroxyquinoline derivatives
Planktonic minimum inhibitory concentrations (PMICs) of analogues of 8-hydroxyquinoline were determined by the broth microdilution method following the M27-A3 protocol [21] . Serial twofold dilutions were made in RPMI 1640 medium, and the final test ranges of concentrations were 0.016-8 µg ml À1 for clioquinol 1 and 0.25-128 µg ml À1 for compounds 2 and 3. The experiments were carried out in quadruplicate. MIC was defined as the lowest concentration of compounds at which the microorganisms tested did not demonstrate visible growth in 48 h.
Cell viability was assessed according to Pippi et al.: the supernatant was discarded and the fungal cells were incubated for 3 h at 35 C in a suspension containing 0.05 mg ml À1 MTT [3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide] (Sigma-Aldrich) [19] . MTT is a tetrazolium salt reduced by dehydrogenase enzymes that form blue formazan crystals, which were then extracted with isopropanol [22] .
Absorbances (A) were measured on a multi-plate reader SpectraMax-M2 (Molecular Devices, USA) at two wavelengths (570 and 690 nm), and percentage cell damage was calculated by the following equation: percentage planktonic cell damage=[1 -(A570 -A690 with drugs)/(A570 -A690 without drugs)]Â100 [19] .
Statistical analysis was performed by both one-way ANOVA and Tukey's multiple comparison test. P 0.05 was considered statistically significant. The analyses were performed using Minitab version 17.0 for software (Minitab Inc., State College, PA).
Effect of coating the wells of a microtitre plate with 8-hydroxyquinoline derivatives on Candida sp. biofilm formation A modified assay was used in which the wells of a microtitre plate were directly precoated with 8-hydroxyquinoline derivatives, in order to investigate the compounds' ability to prevent Candida biofilm formation [23] . Briefly, 100 µl volumes of serial dilutions of 8-hydroxyquinoline derivatives (clioquinol 1: 0.125-64 µg ml
À1
; compounds 2 and 3 : 1-512 µg ml
) were added to selected wells of a microtitre plate and incubated at 4 C for 48 h. After incubation, excess 8-hydroxyquinoline derivatives were aspirated and the plates were washed once in sterile saline. Candida cells cultured for 24 h on Sabouraud dextrose agar (SDA; HiMedia, Mumbai, India) were resuspended at a concentration of 10 6 c.f.u. ml À1 in RPMI 1640 and then 20 µl of these fungal inoculums were added to each well of microtiter plate and the wells were filled with 180 µl of RPMI 1640 (1 : 10 dilution). The plates were incubated for 48 h at 35 C to allow biofilm formation. 
Susceptibility of Candida biofilms to 8-hydroxyquinoline derivatives
To test the susceptibility of Candida biofilms to 8-hydroxyquinoline derivatives, the sessile MIC (SMIC) was determined according to the literature, with certain modifications [25] [26] [27] . Candida cells cultured for 24 h on SDA were resuspended at a concentration of 10 6 c.f.u. ml À1 in RPMI 1640, and then 20 µl of these fungal inocula were added to each well of a microtitre plate and the wells were filled with 180 µl of RPMI 1640. The plates were then incubated for 48 h at 35 C to allow biofilm formation. To remove non-adherent cells, the contents of the wells were aspirated and washed three times with sterile saline. The remaining attached fungi were exposed to serial dilutions of 8-hydroxyquinoline derivatives (clioquinol 1 : 0.125-64 µg ml
À1
) and incubated for 48 h at 35 C. After incubation, excess 8-hydroxyquinoline derivatives were aspirated and the plates were washed three times with sterile saline to remove non-adherent cells.
The effect of 8-hydroxyquinoline derivatives on preformed biofilms was then estimated using the XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] reduction assay. The XTT assay is a quantification technique based on the metabolic activity of viable cells, and the reduction of the XTT dye to a water-soluble formazan are measured [27] . Briefly, XTT (Sigma-Aldrich) was prepared as a saturated solution at a concentration of 0.5 mg ml À1 in MOPS buffer and stored at À70 C until use. Before use an aliquot of the XTT stock solution was thawed, and menadione (10 mM prepared in acetone; Sigma-Aldrich) was added to a final concentration of 1 mM. A 100 µl aliquot of XTT-menadione was then added to each well. The plates were then incubated in the dark for 2 h at 37 C and 75 µl of each well was transferred to a clean 96-well microtitre plate. The assay was performed in triplicate. The colorimetric change at 490 nm (a reflection of the metabolic activity of the biofilm) was measured with a multiplate reader (SpectraMax); the absorbance is proportional to the numbers of metabolically active microbial cells. The antifungal effect of 8-hydroxyquinoline derivatives on Candida sp. biofilm was expressed as the percentage of the mean optical density (OD) of 8-hydroxyquinoline derivative-treated wells compared to the untreated control. This percentage value was calculated by the following equation: percentage inhibition of preformed biofilm=[1 -(A490 treated biofilm)/(A490 untreated biofilm)]Â100.
Reduction of absorption by 50 and 90 % was reported as SMIC 50 and SMIC 90 , respectively. Statistical analysis was performed with both one-way ANOVA and Tukey's multiple comparison test. P 0.05 was considered statistically significant. The analyses were performed using Minitab version 17.0 for software (Minitab Inc.).
Effect on biofilm removal by 8-hydroxyquinoline derivatives
To test the effect on biofilm removal by 8-hydroxyquinoline derivatives, the method of Ramage et al. was applied with certain modifications [27] . Candida cells cultured for 24 h on SDA were re-suspended at a concentration of 10 6 c.f.u. ml À1 in RPMI 1640, and 20 µl of these fungal inocula were then added to each well of a microtitre plate and the wells were filled with 180 µl of RPMI 1640. The plates were incubated for 48 h at 35 C to allow biofilm formation. To remove non-adherent cells, the contents of the wells were aspirated and washed three times with sterile saline. The remaining attached fungi were exposed to serial dilutions of 8-hydroxyquinoline derivatives (clioquinol 1 : 0.125-64 µg ml
À1
) and incubated for 48 h at 35 C. After incubation, excess 8-hydroxyquinoline derivatives were aspirated and the plates were washed three times with sterile saline to remove non-adherent cells. The attached cells were fixed with methanol and the effect on biofilm removal by 8-hydroxyquinoline derivatives was determined by the addition of 0.5 % crystal violet as previously described [24] . The assay was performed in triplicate.
Absorbances (A) were measured on a multi-plate reader (SpectraMax) at 450 nm; the values are proportional to the quantity of total biofilm biomass. Crystal violet is suitable for measuring the amount of biofilm, but not its activity, so crystal violet staining can be used to measure removal but not disinfection [28] . The percentage removal effect of 8-hydroxyquinoline derivatives on Candida sp. biofilm is expressed as the percentage of the mean optical density (OD) of 8-hydroxyquinoline derivative-treated wells compared to the untreated control. This percentage was calculated by the following equation: percentage biofilm removal (BR)=[1 -(A450 treated biofilm)/(A450 untreated biofilm)]Â100.
Reduction of absorption by 50 and 90 % was reported as BR 50 and BR 90 , respectively. Statistical analysis was performed with both one-way ANOVA and Tukey's multiple comparison test. P 0.05 was considered statistically significant. The analyses were performed using Minitab version 17.0 for software (Minitab Inc.).
Biofilm formation assay on IUDs and action of clioquinol Candida cells cultured for 24 h on SDA were re-suspended at a concentration of 10 6 c.f.u. ml À1 in peptone water (pH=4.5, simulated vaginal conditions; HiMedia). A 1 : 10 dilution of this suspension was made by adding 3 ml of fungal suspension to 27 ml of peptone water. The IUDs (Model TCu 380A, Furp -adopted by the Brazilian Ministry of Health for patients in the public health system) were placed in this yeast suspension for 48 h at 35 C to allow biofilm formation. Subsequent to the incubation period, the devices were washed three times with sterile water for removal of the non-adhered cells. Two further steps were then performed.
Step 1: IUDs containing adherent cells were exposed for 8 h (approximate time that a vaginal cream stays in contact) at 35 C to 64 µg ml À1 of clioquinol 1 or fluconazole prepared in 30 ml of peptone water. The same procedure was performed with IUDs exposed to peptone water without the addition of an antifungal agent (untreated control). After the incubation period, 10 µl were aseptically pipetted from each flask and serially diluted tenfold (to 10
À3
) with sterile water. Then, 10 µl (directly) from the flask and 10 µl of each dilution were seeded in SDA to allow the determination of the extant c.f.u. removed from the device by antifungal agents.
Step 2: The IUDs were added to another flask containing 30 ml of sterile water, and the adherent cells were removed from the device by sonication at a frequency of 40 KHz for 10 min. The sonicated water phase was serially diluted tenfold (to 10
) with sterile water and seeded in SDA to determine the extant c.f.u. adherent to the IUDs after contact with the antifungal agent. 
RESULTS
The biofilm-forming capacity of various Candida species on microtitre plates was confirmed in our study once the untreated control was evaluated in parallel in the crystal violet assay and all strains were shown as being biofilm formers. The 8-hydroxyquinoline derivatives were used to prevent biofilm formation and to treat preformed biofilm in order to inhibit or remove this. The results for planktonic MICs (PMICs), inhibition of biofilm formation, sessile MICs (SMICs) and biofilm removal by 8-hydroxyquinoline derivatives are shown in Table 1 . The action of various concentrations of clioquinol 1 and compounds 2 and 3 on planktonic cells and C. albicans biofilms is shown in Fig. 2 .
We observed that precoating the micro-plates with clioquinol 1 prevented the successful adherence and germination of the yeast cells, resulting in scant biofilms. Clioquinol 1 at 16 and 32 µg ml À1 inhibited over 90 % of biofilm formation, except for C. krusei CK Den43, for which the concentrations of clioquinol 1 tested inhibited only 50 %. However, the 8-hydroxyquinoline derivatives 2 and 3 showed only 50 % inhibition on some strains.
In addition, a sharp reduction in the metabolic activity of cells within the biofilm, as assessed by the XTT reduction assay (susceptibility of biofilms), was demonstrated when preformed biofilms of C. albicans ATCC 18804, C. glabrata CG RL24 and C. parapsilosis CP RL 38 were exposed to clioquinol 1. The 8-hydroxyquinoline derivatives 2 and 3 reduced more than 50 % of the biofilm metabolic activity of only certain strains (compound 2 for ATTCC 18804 and CG RL24; compound 3 for CG RL24).
On the other hand, the complete removal of biofilm was not achieved by treatment with 8-hydroxyquinoline derivatives. Clioquinol 1 removed over 90 % only for the biofilm of C. glabrata CG RL24. However, the 8-hydroxyquinoline derivative-treated biofilms had less biomass compared to the untreated control, presenting 50 % removal in some cases.
Candida spp. showed an ability to form biofilm on copper IUDs. These presented between 1.13Â10 5 and 4.72Â10 7 c.f.u., depending on the species. Candida albicans was the strongest biofilm-forming species on these IUDs, followed by C. tropicalis, C. parapsilosis, C. glabrata and C. krusei. The c.f.u. values for both treated and untreated IUDs, as well as the percentage of biofilm eradication by clioquinol 1 and fluconazole, are shown in 
DISCUSSION
Biofilms have unique developmental characteristics and are in general much more difficult to treat [8, 9] . In the current era of widespread antimicrobial resistance, the evaluation of the use of current and novel antifungal agents against cells in biofilms is crucial [8] . Research on the antifungal activity of 8-hydroxyquinoline derivatives has been developed for planktonic fungal cells; however, investigation of a sessile microbial lifestyle has been neglected. An attractive option for control of biofilm formation is to coat biomaterials with antifungal agents in order to prevent the colonization of cells. As shown in Fig. 2(b) , coating with clioquinol 1 resulted in a reduction in adherent cells and prevention of more than 90 % of biofilm formation. Compounds 2 and 3 showed more than 50 % reduction in biofilm biomass, but they were less potent than clioquinol 1 (Fig. 2f, j) .
We previously demonstrated that clioquinol 1 inhibited pseudo-hyphal formation in C. albicans, and this finding is possibly related to the results from the present study [29] . The dimorphic transition from a yeast form to a hyphal form represents an essential aspect of the pathogen's biology. It is linked to essential properties for interaction with the host, such as adhesion to epithelial and endothelial cells, and appears to be a pivotal biological process required for biofilm formation [30, 31] . Ramage et al. demonstrated that C. albicans mutant strains that could not germinate were unable to form biofilms [32] . Studies conducted by Baillie et al. concluded that hyphae are essential elements for providing structural integrity and the multi-layered architecture that is characteristic of mature biofilms [33] . Our results thus indicate that the marked reduction in C. albicans biofilm density is likely attributed to a direct consequence of the inhibitory effect of clioquinol 1 on the morphogenetic process. Similar results were found by Ramage et al. [34] . They showed that EDTA blocks hyphal development in C. albicans and that this chelating agent may also affect biofilm formation [34] .
In addition to its importance in biomaterials, biofilm formation is also an important virulence factor for Candida spp. because it protects cells from host immune responses [35] . Thus, clioquinol 1 might also contribute to reducing the virulence factor that assists pathogenesis, because it inhibits dimorphic transition (unpublished results) and reduces biofilm formation.
When infection by Candida is established, antifungal treatment without implant removal is rarely effective and thus device removal is considered a prerequisite for successful therapy [31, 36] . Susceptibility studies to 8-hydroxyquinoline derivatives demonstrated an increase from PMIC 50 and 90 to the corresponding SMIC 50 and 90 , a characteristic of Candida biofilms previously described by other authors [25, 37, 38] . Although our study demonstrates the efficacy of clioquinol 1 in reducing the metabolic activity of sessile Candida (ATCC 18804, CG RL32 and CP RL38), the SMIC90 values of clioquinol 1 were increased 128-to 512-fold over PMIC90. Similarly, Khan and Ahmad observed that the SMIC of amphotericin B and fluconazole was increased by 16-to 512-and by 8-to 1024-fold, respectively [38] . Shuford et al. found increased SMIC for amphotericin, caspofungin and voriconazole [25] . Hawser and Douglas also found that biofilms were more resistant to amphotericin B, fluconazole, flucytosine, itraconazole and ketoconazole than planktonic cells [37] . A marked reduction in the metabolic activity of cells within the biofilm was also observed when preformed Candida biofilms were exposed to 8-hydroxyquinoline-sulfonic acid. However, contrary to the results for clioquinol 1, these derivatives reduced less than 90 % of the metabolic activity of sessile Candida within mature biofilms, even at high concentrations. Based on these results, we noted a clear structure-activity relationship. It seems that the presence of the appropriate substituents at the phenyl ring (5-chloro and 7-iodo) is essential for efficacy in reducing the metabolic activity of sessile Candida.
We also evaluated the ability of 8-hydroxyquinoline derivatives to remove biofilm from microtitre plates. It was observed that these compounds were less effective in removing the preformed biofilm, since the concentrations required for this action were higher than those required for inhibition of both biofilm formation and the metabolic activity of the preformed biofilm. Removal of 50% of biofilm was achieved with high concentrations of clioquinol 1 (16-64 µg ml
À1
), and almost complete removal of biofilm was obtained only for C. glabrata RL24. In addition, compounds 2 and 3 removed only 50 % of the biofilm biomass of one and two strains, respectively. Therefore, after observing the results from the micro-plate, we chose clioquinol 1 as the representative of 8-hydroxyquinoline derivatives to evaluate the effects on preformed biofilm in IUDs. Initially, the biofilm-forming capacity of various Candida species was confirmed by counts of cells grown on the IUD surface. Chassot et al. also described the ability of C. albicans to form biofilm on copper IUDs [4] , but studies with non-albicans species have not been reported to date. These authors noted that the cells adhered strongly to the three parts of the IUD (copper-covered part, part without copper and tail) [4] . In addition, other studies have proposed that the IUD tail is a major factor in the migration of vaginal microorganisms of into the endometrial cavity [4, 39] . Once the yeast reaches the endometrial cavity, the copper-covered parts appear to contribute to the retention of the microorganism at that site [3] [4] [5] .
Interestingly, fungal biofilm in IUDs has rarely been studied. This lack of interest is worrying, because IUDs are extraneous surfaces implanted for long periods in the uterine mucosa [3] . More than 80 million women use IUDs as a contraceptive method [3] , and those removed from women were shown to be highly contaminated with C. albicans [39] . Demirezen et al. showed that IUD users had higher levels of Candida infection than non-users [40] . In addition, IUD retention may cause serious clinical complications and VVC has been resolved with removal of these devices [4, 41] . Therefore, understanding the action of antifungal agents on IUDs is essential.
In the present study we found that clioquinol 1 was very effective, especially for C. glabrata, since total biofilm eradication from the device was shown. C. glabrata is known to be resistant to antifungals, and therefore eradication of biofilms of this species is a very important finding [42, 43] . Clioquinol 1 was also extremely effective for C. albicans and C. tropicalis, the two species that formed biofilm most strongly. In addition, the data showed that clioquinol 1 resulted in higher biofilm eradication than fluconazole, regardless of species. Fluconazole showed a low level of eradication (<70 %) for C. krusei and C. parapsilosis biofilms. Such findings are very relevant because azole antifungals, especially fluconazole, are widely used to treat VVC [44] . The efficient eradication of IUD biofilms, associated with rare reports of fungal resistance to clioquinol 1, may CA, C. albicans; CG, C. glabrata; CK, C. krusei; CP, C. parapsilosis; CT, C. tropicalis. c.f.u., colony-forming units.
imply that this drug is an important option for treating recurrent VVC associated with IUD use.
In conclusion, our data showed varying levels of attenuation of formation, reduction in metabolic activity and removal of Candida biofilm in the presence of 8-hydroxyquinoline derivatives in a concentration-dependent manner. Finally, the results indicate a potential application as biomaterials for 8-hydroxyquinoline derivatives, especially clioquinol 1. This drug could be used as a coating to prevent morphological switching from yeast to hyphae and hence avoidance of biofilm formation. Furthermore, clioquinol 1 may have future applications in the treatment of Candida infections linked to the use of IUDs. Finally, this is the first protocol to quantify the inhibitory action of compounds on biofilms formed on the IUD surface. 
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